Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed route for C-3 benzyl indolizines offers simplified operations and high substrate tolerance, ensuring reliable supply for anticancer drug development.
Patent CN108864164B details a green, water-based synthesis of 2-alkynyl indoles using primary amine guidance, offering cost-effective solutions for API manufacturing.
Patent CN115215814A details a novel Rh-catalyzed C-H activation route to isoxazolidines, offering mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply.
Patent CN108690007B reveals a room-temperature ionic liquid method for ortho-cyanation, offering safer pharma intermediate manufacturing and reduced waste.
Patent CN115636829B reveals efficient Rh-catalyzed synthesis. High yield, scalable process for organic luminescent materials.
Patent CN113620795B details a novel Rh-catalyzed route to benzocycloheptenones. Discover cost-effective API intermediate manufacturing with high scalability.
Patent CN114014802A details a mild Pd-catalyzed dehydrogenative coupling for enamides, offering cost reduction in pharmaceutical intermediate manufacturing via scalable routes.
Novel Ru-catalyzed C-H activation method for benzindole derivatives offers mild conditions and green solvents, ensuring reliable supply chain and cost efficiency.
Patent CN112538045A reveals a mild copper-catalyzed route to quinolines, offering cost reduction in API manufacturing and scalable green chemistry solutions.
Novel rhodium-catalyzed route offers high purity trifluoromethyl enaminones. Reduces manufacturing costs and ensures supply chain reliability for global pharmaceutical partners.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation route for tetrahydro-beta-carbolinones, offering a cost-effective alternative to palladium methods for API manufacturing.
Efficient cobalt-catalyzed C-H activation for 2-alkoxyindole compounds. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108929262B details a Rh(III)-catalyzed cascade synthesis of benzo[a]carbazoles. This method offers mild conditions and broad substrate scope for OLED and pharma applications.
Patent CN106632393B reveals safe scalable PA-824 synthesis avoiding explosive materials ensuring supply chain stability and cost efficiency for global buyers.
Patent CN115286609B reveals efficient ruthenium-catalyzed route. Enables high-purity pharmaceutical intermediates with reduced operational risks and scalable production capabilities.
Patent CN109776546B details a high-yield Re-catalyzed synthesis of indolopyrrolones, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Patent CN115772157B reveals cobalt-catalyzed route for 2-alkoxyindoles offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113735756A details a mild Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and cost-effective manufacturing solutions.
Novel Pd-catalyzed cyanation of indoles using tert-butyl isonitrile. Safe, scalable route for API intermediates replacing toxic metal cyanides.
Patent CN111285846B details a novel Rh-catalyzed C-H activation route for indole derivatives, offering atom economy and mild conditions for reliable pharmaceutical intermediate supply.